Skip to main content
. Author manuscript; available in PMC: 2012 Dec 1.
Published in final edited form as: Invest New Drugs. 2010 Mar 25;29(6):1432–1440. doi: 10.1007/s10637-010-9420-8

Figure 1. Time to Objective Progression.

Figure 1

Progression at 6 months: 500mg : 91% (2/22 pts not progressing)
2000mg: 77% (5/22 pts not progressing)

Median time to progression was 2.7 months (95% CI 2.66, 2.79) on the 500mg arm and .8 months (95% CI 2.66, 5.85) on the 2000mg arm (log-rank p-value=0.52)